Please login to the form below

Not currently logged in
Email:
Password:

obinutuzumab

This page shows the latest obinutuzumab news and features for those working in and with pharma, biotech and healthcare.

EU grants approval for Venclyxto/Gazyvaro combo in CLL

EU grants approval for Venclyxto/Gazyvaro combo in CLL

CLL). Venclyxto (venetoclax) – known as Venclexta in the US – was co-developed by AbbVie and Roche and the combination with Gazyva (obinutuzumab) in frontline treatment of CLL could see its use

Latest news

More from news
Approximately 11 fully matching, plus 29 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Pegasus

Pegasus inspires healthy decisions through creative, inspirational and integrated communications. Working with ambitious clients, we deliver big ideas and far-reaching...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics